Integrated immunohistochemical and DNA copy number profiling analysis provides insight into the molecular pathogenesis of canine follicular lymphoma

Follicular lymphomas (FLs) typically exhibit a chromosome translocation that induces constitutive expression of the anti-apoptotic bcl2 protein and accumulation of additional molecular defects. This rearrangement offers a promising therapeutic target, but its nature as a fundamental driver of FL pathogenesis remains unclear as 15% of cases lack the translocation. We performed an integrated immunohistochemical and genomic investigation of 10 naturally occurring FL cases from domestic dogs, showing that, as with human tumours, they exhibit marked heterogeneity in the frequency and intensity of bcl2 protein expression. Genomic copy number aberrations were infrequent and broadly consistent with those of other canine B-cell lymphoma subtypes. None of the canine FL specimens exhibited a rearrangement consistent with the hallmark translocation of human FL, despite their remarkable histomorphologic similarity. Parallel exploration of canine and human cases may reveal alternative tumour-initiating mechanisms other than BCL2 disruption, yielding a more complete definition of the molecular pathogenesis of FL.

[1]  K. Campbell,et al.  Coordinate expression of cytokeratins 7 and 14, vimentin, and Bcl-2 in canine cutaneous epithelial tumors and cysts , 2015, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[2]  Daniel M. Rotroff,et al.  Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation , 2015, Chromosome Research.

[3]  İrfan Yavaşoğlu,et al.  Follicular Lymphoma , 2015, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[4]  E. Mauceli,et al.  Genome-wide Association Study Identifies Shared Risk Loci Common to Two Malignancies in Golden Retrievers , 2015, PLoS genetics.

[5]  R. Gascoyne,et al.  The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.

[6]  D. Huang,et al.  Targeting BCL2 for the treatment of lymphoid malignancies. , 2014, Seminars in hematology.

[7]  B. Nadel,et al.  Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? , 2014, Blood.

[8]  A. Kwiecińska,et al.  Amplification of 2p as a Genomic Marker for Transformation in Lymphoma , 2014, Genes, chromosomes & cancer.

[9]  Renu Malhotra,et al.  IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.

[10]  A. Freedman,et al.  Follicular lymphoma: 2014 update on diagnosis and management , 2014, American journal of hematology.

[11]  L. Staudt,et al.  Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. , 2014, Blood.

[12]  Daniel M. Rotroff,et al.  Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma , 2014, Chromosome Research.

[13]  Raul Rabadan,et al.  Genetics of follicular lymphoma transformation. , 2014, Cell reports.

[14]  K. Lindblad-Toh,et al.  Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B , 2013, Genome Biology.

[15]  D. de Jong,et al.  Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features , 2013, Haematologica.

[16]  J. Modiano,et al.  Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy. , 2013, Veterinary clinical pathology.

[17]  E. Seiser,et al.  Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines. , 2013, Veterinary and comparative oncology.

[18]  K. Fu,et al.  Frequencies of BCL2 and BCL6 Translocations in Representative Chinese Follicular Lymphoma Patients: Morphologic, Immunohistochemical, and FISH Analyses , 2012, Diagnostic molecular pathology (Print).

[19]  K. Tarte,et al.  Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis , 2012, Front. Immun..

[20]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[21]  K. Lindblad-Toh,et al.  Refining tumor-associated aneuploidy through ‘genomic recoding’ of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas , 2011, Leukemia & lymphoma.

[22]  A. Rosenwald,et al.  Pathology, pathogenesis and molecular genetics of follicular NHL. , 2011, Best practice & research. Clinical haematology.

[23]  S. Montoto,et al.  Transformation of indolent B-cell lymphomas. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Rothberg,et al.  Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens. , 2011, The Journal of molecular diagnostics : JMD.

[25]  M. Miller,et al.  Classification of Canine Malignant Lymphomas According to the World Health Organization Criteria , 2011, Veterinary pathology.

[26]  D. Haines,et al.  Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. , 2010, The Canadian veterinary journal = La revue veterinaire canadienne.

[27]  Allen D. Delaney,et al.  High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genes , 2010, Genes, chromosomes & cancer.

[28]  C. Bonnefont,et al.  A Morphological Study of 608 Cases of Canine Malignant Lymphoma in France With a Focus on Comparative Similarities Between Canine and Human Lymphoma Morphology , 2010, Veterinary pathology.

[29]  L. Mazzucchelli,et al.  BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. , 2009, Human pathology.

[30]  P. Tsai,et al.  Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma , 2009, Chromosome Research.

[31]  R. Spang,et al.  Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status , 2009, Genes, chromosomes & cancer.

[32]  L. Staudt,et al.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. , 2007, Blood.

[33]  J. Modiano,et al.  Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship , 2008, Chromosome Research.

[34]  J. Cyster,et al.  Germinal-center organization and cellular dynamics. , 2007, Immunity.

[35]  P. Ouillette,et al.  Comprehensive Analysis of Copy Number and Allele Status Identifies Multiple Chromosome Defects Underlying Follicular Lymphoma Pathogenesis , 2007, Clinical Cancer Research.

[36]  D. Weisenburger,et al.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.

[37]  James A. Cuff,et al.  Genome sequence, comparative analysis and haplotype structure of the domestic dog , 2005, Nature.

[38]  J. D'haese,et al.  Chromosomal aberrations in follicular non-Hodgkin lymphomas of Japanese patients, detected with comparative genomic hybridization and polymerase chain reaction analysis. , 2005, Cancer genetics and cytogenetics.

[39]  Paul R. Avery,et al.  Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. , 2005, Cancer research.

[40]  G. Mahairas,et al.  An integrated 4249 marker FISH/RH map of the canine genome , 2004, BMC Genomics.

[41]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[42]  C. Robertson,et al.  Update on diabetes diagnosis and management. , 2003, Journal of the American Dental Association.

[43]  H. Ohno,et al.  Heterogeneous Breakpoints on the Immunoglobulin Genes Are Involved in Fusion with the 5′ Region of BCL2 in B‐Cell Tumors , 2001, Japanese journal of cancer research : Gann.

[44]  J Hermans,et al.  Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. , 1998, Blood.

[45]  F. Berger,et al.  FVT-1, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. , 1993, Blood.

[46]  D. de Jong,et al.  Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. , 1991, Oncogene.

[47]  M. Kimmel,et al.  Lymphomas in dogs a morphologic, immunologic, and clinical study , 1990, Cancer.

[48]  Lee G Luna,et al.  Manual of histologic staining methods of the Armed forces institute of pathology , 1968 .